{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T15:07:19Z","timestamp":1720192039189},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["NHMRC, APP 1104184"],"award-info":[{"award-number":["NHMRC, APP 1104184"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.psychres.2018.03.030","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T18:31:58Z","timestamp":1521225118000},"page":"317-322","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The effects of antipsychotics on the density of cannabinoid receptors in selected brain regions of male and female adolescent juvenile rats"],"prefix":"10.1016","volume":"266","author":[{"given":"Jiamei","family":"Lian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2018.03.030_bib0001","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1073858403252674","article-title":"Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia","volume":"9","author":"Abi-Dargham","year":"2003","journal-title":"Neuroscientist"},{"key":"10.1016\/j.psychres.2018.03.030_bib0002","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2014.01.039","article-title":"Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain","volume":"153","author":"Almeida","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.03.030_bib0003","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0306-4522(98)00675-7","article-title":"Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function","volume":"91","author":"Alonso","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2018.03.030_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-7634(03)00005-8","article-title":"Trajectories of brain development: point of vulnerability or window of opportunity?","volume":"27","author":"Andersen","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2018.03.030_bib0005","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00213-001-0933-x","article-title":"Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats","volume":"159","author":"Aravagiri","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2018.03.030_bib0006","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.psychres.2018.03.030_bib0007","first-page":"177","article-title":"A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial","volume":"14","author":"Berk","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0008","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/nbdi.1998.0229","article-title":"The functional neuroanatomy of brain cannabinoid receptors","volume":"5","author":"Breivogel","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.psychres.2018.03.030_bib0009","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the CB(2) cannabinoid receptor in immune regulation and therapeutic prospects","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.psychres.2018.03.030_bib0010","first-page":"129","article-title":"Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia","volume":"56","author":"Ceccarini","year":"2014","journal-title":"Tijdschrift Voor Psychiatrie"},{"key":"10.1016\/j.psychres.2018.03.030_bib0011","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S1461145707008048","article-title":"Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex","volume":"11","author":"Cheng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0012","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","article-title":"From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics","volume":"2","author":"Correll","year":"2010","journal-title":"Eur. Psychiatry 25 Suppl"},{"key":"10.1016\/j.psychres.2018.03.030_bib0013","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2011.43","article-title":"Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex","volume":"36","author":"Dalton","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2018.03.030_bib0014","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(03)00150-3","article-title":"Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover","volume":"75","author":"Darmani","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2018.03.030_bib0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12264-007-0051-9","article-title":"No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia","volume":"23","author":"Deng","year":"2007","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.psychres.2018.03.030_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/0269881112449396","article-title":"Reducing olanzapine-induced weight gain side-effect by betahistine: a study in the rat model","volume":"26","author":"Deng","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0017","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1113\/jphysiol.2004.067470","article-title":"Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve","volume":"559","author":"Derbenev","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0018","first-page":"2635","article-title":"Aripiprazole: from pharmacological profile to clinical use","volume":"11","author":"Di Sciascio","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2018.03.030_bib0019","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-009-1671-8","article-title":"Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse","volume":"207","author":"Feltenstein","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2018.03.030_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuint.2012.05.009","article-title":"Presynaptic CB1 cannabinoid receptors control frontocortical serotonin and glutamate release \u2013 Species differences","volume":"61","author":"Ferreira","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.psychres.2018.03.030_bib0021","first-page":"24","article-title":"The endocannabinoid-CB receptor system: Importance for development and in pediatric disease","volume":"25","author":"Fride","year":"2004","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.psychres.2018.03.030_bib0022","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-642-25761-2_2","article-title":"Role of dopamine D(2) receptors for antipsychotic activity","author":"Ginovart","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.psychres.2018.03.030_bib0023","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2018.03.030_bib0024","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2217\/pgs.09.102","article-title":"Sex-specific differences in side effects of psychotropic drugs: genes or gender?","volume":"10","author":"Haack","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.psychres.2018.03.030_bib0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2018.03.030_bib0026","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2018.03.030_bib0027","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.03.030_bib0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2012.07.021","article-title":"Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia","volume":"141","author":"Jenko","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.03.030_bib0029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2007.09.022","article-title":"The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons","volume":"578","author":"Lau","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0013-7006(07)92047-3","article-title":"Clinical impact of aripiprazole in patients suffering from schizophrenia","volume":"33","author":"Levoyer","year":"2007","journal-title":"Encephale"},{"key":"10.1016\/j.psychres.2018.03.030_bib0031","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hipo.22558","article-title":"Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus","volume":"26","author":"Li","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.psychres.2018.03.030_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104160","article-title":"Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment","volume":"9","author":"Lian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2018.03.030_bib0033","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.pharep.2016.06.003","article-title":"Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats","volume":"68","author":"Lian","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.psychres.2018.03.030_bib0034","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-8993(03)02872-5","article-title":"Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes","volume":"979","author":"Liu","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2018.03.030_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lfs.2015.01.033","article-title":"Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats","volume":"128","author":"Liu","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.psychres.2018.03.030_bib0036","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/0269881106063816","article-title":"Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys","volume":"20","author":"Madsen","year":"2006","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.psychres.2018.03.030_bib0037","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","article-title":"GPCR functional selectivity has therapeutic impact","volume":"28","author":"Mailman","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2018.03.030_bib0038","first-page":"488","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr","volume":"16","author":"Mailman","year":"2010","journal-title":"Pharm. Des."},{"key":"10.1016\/j.psychres.2018.03.030_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Current Opinion Pharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jad.2011.05.023","article-title":"Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor","volume":"134","author":"Minocci","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2018.03.030_bib0041","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.psychres.2018.03.030_bib0042","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2012","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.psychres.2018.03.030_bib0043","doi-asserted-by":"crossref","DOI":"10.4303\/jdar\/235714","article-title":"Cannabinoid receptor gene variations in drug addiction and neuropsychiatric disorders","volume":"2","author":"Onaivi","year":"2013","journal-title":"J. Drug Alcohol Res."},{"key":"10.1016\/j.psychres.2018.03.030_bib0044","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2018.03.030_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-8993(02)03797-6","article-title":"Cannabinoid-induced Fos expression within A10 dopaminergic neurons","volume":"963","author":"Patel","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2018.03.030_bib0046","series-title":"The Rat Brain in Sterotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.psychres.2018.03.030_bib0047","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.biopsych.2015.08.021","article-title":"Reduced brain cannabinoid receptor availability in schizophrenia","volume":"79","author":"Ranganathan","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.03.030_bib0048","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00787-014-0669-x","article-title":"Gender effects on brain changes in early-onset psychosis","volume":"24","author":"Rapado-Castro","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2018.03.030_bib0049","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fnins.2014.00361","article-title":"Long-term consequences of adolescent cannabinoid exposure in adult psychopathology","volume":"8","author":"Renard","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psychres.2018.03.030_bib0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/070674371305800608","article-title":"A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011","volume":"58","author":"Ronsley","year":"2013","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.03.030_bib0051","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.npp.1301395","article-title":"Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia","volume":"33","author":"Rubin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2018.03.030_bib0052","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.psc.2010.01.006","article-title":"Gender differences in attention-deficit\/hyperactivity disorder","volume":"33","author":"Rucklidge","year":"2010","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.psychres.2018.03.030_bib0053","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1369-1600.2008.00110.x","article-title":"Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure","volume":"13","author":"Schneider","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0054","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000245220","article-title":"Risperidone Treatment Increases CB<sub>1<\/sub>Receptor Binding in Rat Brain","volume":"91","author":"Secher","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psychres.2018.03.030_bib0055","unstructured":"Society, T.N.A., 2017. Gender and Autism."},{"key":"10.1016\/j.psychres.2018.03.030_bib0056","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity","volume":"8","author":"Soethoudt","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.psychres.2018.03.030_bib0057","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00210-005-1074-2","article-title":"Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens","volume":"371","author":"Sundram","year":"2005","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0058","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.tpj.6500418","article-title":"No evidence for binding of clozapine, olanzapine and\/or haloperidol to selected receptors involved in body weight regulation","volume":"7","author":"Theisen","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.psychres.2018.03.030_bib0059","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.euroneuro.2008.03.001","article-title":"Cannabinoid and opioid modulation of social play behavior in adolescent rats: differential behavioral mechanisms","volume":"18","author":"Trezza","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0061","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1254\/jphs.FMJ04003X4","article-title":"New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia","volume":"96","author":"Ujike","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2018.03.030_bib0062","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1460-9568.2008.06484.x","article-title":"The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro","volume":"28","author":"Vitalis","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psychres.2018.03.030_bib0063","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1017\/S1461145708008560","article-title":"The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain","volume":"11","author":"Weston-Green","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2018.03.030_bib0064","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neuropharm.2008.07.026","article-title":"Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats","volume":"55","author":"Wiley","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2018.03.030_bib0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117315883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117315883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T20:58:36Z","timestamp":1560200316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178117315883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":65,"alternative-id":["S0165178117315883"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.03.030","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of antipsychotics on the density of cannabinoid receptors in selected brain regions of male and female adolescent juvenile rats","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}